Stay updated on Nivolumab for High-Risk Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk Prostate Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added. Prostate cancer and related topic MedlinePlus Genetics were removed; Revision: v3.3.1 was removed.
    Difference
    0.2%
    Check dated 2025-11-30T15:33:03.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's metadata was updated to include a 'Prostate cancer' tag and related topic 'MedlinePlus Genetics', and the revision label changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-23T14:54:58.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The government funding operating-status notice has been removed from the page. Core trial information such as description, eligibility, design, and outcome measures remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-16T14:32:29.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The screenshots show only non-substantive UI changes such as overlays or cookie consent prompts and minor layout adjustments that do not affect the study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-02T00:56:53.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added new MedlinePlus Genetics topic: Prostate cancer.
    Difference
    0.3%
    Check dated 2025-10-18T19:08:45.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Added a government funding status notice and new version tag (v3.2.0); removed a specific MedlinePlus Genetics topic (Prostate cancer).
    Difference
    4%
    Check dated 2025-10-04T12:34:53.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.